CESTEX 100MG TABLETS DIN 01912992
Status: Cancelled Post Market
Holder: PFIZER CANADA INC ANIMAL HEALTH GROUP
Health Canada record
| Active ingredient(s) | EPSIPRANTEL 100 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1992 |
|---|
| Current status date | 02-Aug-2010 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
Pfizer Canada ULC — licence 100255, currently licensed, last inspection rating C (2023-08-07).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing EPSIPRANTEL
| DIN | Product | Company | Form | Strength | Status |
|---|
| 01913034 | CESTEX | ZOETIS CANADA INC | Tablet | EPSIPRANTEL 12.5 MG | Marketed |
| 01913026 | CESTEX | ZOETIS CANADA INC | Tablet | EPSIPRANTEL 25 MG | Marketed |
| 01913018 | CESTEX 50MG TABLETS | PFIZER CANADA INC ANIMAL HEALTH GROUP | Tablet | EPSIPRANTEL 50 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 5847 | 1998-06-18 | New Drug Submission (NDS) | |
Request a quote for CESTEX 100MG TABLETS
How to read a Canadian DIN record